Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lung disease
Biotech
NIH loses another leader as heart, lung and blood director exits
Gary Gibbons' retirement as National Heart, Lung and Blood Institute director puts 15 out of 27 institutes and centers under interim leadership.
Nick Paul Taylor
Jan 13, 2026 4:00am
AirNexis swoops in with $200M series A for COPD asset
Jan 9, 2026 11:01am
Daiichi-Merck ph. 3 ADC program on pause after patient deaths
Dec 18, 2025 11:22am
Thermo Fisher launches biopsy test to assess lung rejection risk
Oct 9, 2025 10:50am
aTyr flunks phase 3 lung disease trial, deflating stock
Sep 15, 2025 9:56am
Wave reports AATD win, but investors lukewarm
Sep 3, 2025 3:00pm